Amneal Pharmaceuticals, Inc. (AMRX) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$22,410
Total Return
124.10%
CAGR
17.52%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.42% |
| Median | +2.50% |
| Best | +48.84% |
| Worst | -45.34% |
| % of Windows Positive | 58.8% |
1-Year (252 Trading Days)
| Average | +45.67% |
| Median | +35.56% |
| Best | +377.17% |
| Worst | -70.18% |
| % of Windows Positive | 68.2% |
3-Year (756 Trading Days)
| Average | +216.17% |
| Median | +105.82% |
| Best | +945.86% |
| Worst | -7.06% |
| % of Windows Positive | 99.6% |
Risk Metrics
| Maximum Drawdown | -78.90% |
| Average Drawdown | -24.35% |
| Drawdown Duration | 641 Trading Days |
| Sortino Ratio | 0.88 |
| Calmar Ratio | 0.22 |
| CVaR (5%) | -6.72% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +3.33% (+11.39% ann.) | +$333.34 | $0.00 | $0.00 | $0.00 |
| 2025 | +59.09% | +$5909.09 | $0.00 | $0.00 | $0.00 |
| 2024 | +30.48% | +$3047.77 | $0.00 | $0.00 | $0.00 |
| 2023 | +205.03% | +$20502.57 | $0.00 | $0.00 | $0.00 |
| 2022 | -58.46% | $5845.53 | $0.00 | $0.00 | $0.00 |
| 2021 | +4.81% | +$481.40 | $0.00 | $0.00 | $0.00 |
| 2020 | -5.19% | $518.66 | $0.00 | $0.00 | $0.00 |
| 2019 | -64.38% | $6437.55 | $0.00 | $0.00 | $0.00 |
| 2018 partial | -9.86% (-14.73% ann.) | $986.01 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | May 7, 2018 – February 19, 2020 | -67.42% | -46.60% | $6742.17 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -17.53% | -88.92% | $1753.24 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +14.40% | +24.18% | +$1440.46 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +1.91% | +1.81% | +$190.94 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -46.17% | -48.19% | $4617.23 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +271.01% | +102.86% | +$27100.80 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | +49.48% | +28.81% | +$4948.34 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.